Abstract
The aim of this chapter is to provide the reader of a strategy to decide which instruments to use in case of dual disorder. Depending on the level in the diagnostic process, distinction should be made between the need for screening and than further assessment. Then, several instruments are presented for the screening of substance use or abuse in general psychiatric context and for the screening of comorbidity in treatment context of substance use disorders. Instruments should cover a number of criteria such as reliability and validity, relative easy training and—in a European context—availability in several languages.
Once the screening is able to confirm a suspected diagnosis, rating scales and structured interviews are recommended. In case of substance use disorder, the instruments should be multidimensional and sometimes substance specific. To assess comorbidity, comprehensive clinical experience is basic, beside the use of structured and standardized instruments and rating scales, in order to reduce sources of error. It is concluded that more standardization of the diagnostic process needs to be taken for the future of empirical research in psychiatry to advantage consistency and comparability of data across studies. Next to the need of more standardization of the diagnostic process, standard use of instruments in clinical practice could also enhance communication and alliance between patient and therapist. By incorporating patient and therapist ratings in the assessment process, clinical usefulness, personal relevance, and meaningfulness to the patient could be enhanced.
Keywords
- Mental Health Disorder
- Composite International Diagnostic Interview
- Addiction Severity Index
- Routine Outcome Monitoring
- Dual Disorder
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Adamson SJ, Sellman DJ (2003) A prototype screening instrument for cannabis use disorder: the cannabis use disorders identification test (CUDIT) in an alcohol-dependence clinical sample. Drug Alcohol Rev 22:309–315
Aertgeerts B, Buntinx F, Bande-Knops J et al (2000) The value of CAGE, CUGE and AUDIT in screening for alcohol abuse and dependence among college freshmen. Alcohol Clin Exp Res 24:53–57
Andrews G, Peters L (1998) The psychometric properties of the Composite International Diagnostic Interview. Soc Psychiatry Psychiatr Epidemiol 33:80–88
Baron S, Linden M (2008) The role of the “International Classification of Functioning, Disability and Health, ICF” in the description and classification of mental disorders. Eur Arch Psychiatry Clin Neurosci 258(5):81–85
Baumann U, Eckmann F, Stieglitz RD (1985) Self-rating data as selecting factor in clinical trials of psychotropic drugs. Eur Arch Psychiatry Clin Neurosci 235:65–70
Bryant KJ, Rounsaville B, Spitzer RL et al (1992) Reliability of dual diagnosis. Substance dependence and psychiatric disorders. J Nerv Ment Dis 180:251–257
Clair D, Prendergast D (1994) Brief psychotherapy and psychological assessments: Entering a relationship, establishing focus, and providing feedback. Prof Psychol-Res Pract 25:46–49
Cottler LB (1993) Comparing DSM-III-R and ICD-10 substance use disorders. Addiction 88:689–696
Cottler LB, Robins LN, Grant BF et al (1991) The CIDI-Core substance abuse and dependence questions: cross-cultural and nosological issues. Br J Psychiatry 159:653–658
De Beurs E, Van Dyck R, Marquenie LA et al (2001) DASS: A questionnaire for the measurement of depression, anxiety and stress (De DASS: een vragenlijst voor het meten van depressie, angst en stress). Gedragstherapie 34:35–53
De Meneses-Gaya C, Zuardi AW, Loureiro SR et al (2009) Alcohol Use Disorders Identification Test (AUDIT): an updated systematic review of psychometric properties. Psychol Neurosci 2:83–97
De Weert-Van Oene G, de Jong C, Raes V et al (2013) Problem identification, diagnostic and monitoring in case of double diagnosis (Probleemidentificatie, diagnostiek en monitoring bij dubbele diagnose). In: Dom G, Dijkhuizen A et al (eds) Handbook double diagnosis (Handboek Dubbele Diagnose). De Tijdstroom, Utrecht, pp 41–53
Dom G, Raes V, van den Brink W (2004) Instruments for measuring addictive disorders [Meetinstrumenten bij stoornissen in het gebruik van middelen. Tijdschr Psychiatr 46:671–674
Helzer JE (1983) Standardized instruments in psychiatry. Psychiat Dev 1:161–178
Hiller W, Zaudig M, Mombour W et al (1993) Routine psychiatric examinations guided by ICD-10 diagnostic checklists (International Diagnostic Checklists). Eur Arch Psychiatry Clin Neurosci 242:218–223
Hunsley J, Mash EJ (2005) Introduction to the special section on developing guidelines for the Evidence-Based Assessment (EBA) of adult disorders. Psychol Assess 17:251–255
Janca A, Ustun TB, van Drimmelen J et al (1994) ICD-10 Symptom Checklist for Mental Disorders (ICD-10 SCL, Version 2.0). WHO, Geneva
Joosten E (2009) Let’s decide together. Shared decision-making in addiction health care. Dissertation, Radboud University Nijmegen
Kerkmeer M, Blanken P, de Klerk C (2003) Double diagnosis, double aid. Diagnostic guidelines and treatment (Dubbele Diagnose, dubbele hulp. Richtlijnen voor diagnostiek en behandeling). Parnassia, Den Haag
Kosten TR, Bryant K, Rounsaville BJ (1990) The SCID: a clinical instrument for assessing psychiatric disorders. NIDA Res Monogr 105:213–219
Maisto SA, Carey MP, Carey KB et al (2000) Use of the AUDIT and the DAST-10 to identify alcohol and drug use disorders among adults with a severe and persistent mental illness. Psychol Assess 12:186–192
Marsden J, Gossop M, Stewart D, Best D, Farrell M, Lehman P et al (1998) The Maudsley Addiction Profile (MAP): a brief instrument for assessing treatment outcome. Addiction 93:1857–1867
Mestre-Pintó JI, Domingo-Salvany A, Martin-Santos R, Torrens M et al (2014) Dual diagnosis screening interview to identify psychiatric comorbidity in substance users: development and validation of a brief instrument. Eur Addict Res 20:41–48
Mills LK, Deady M, Proudford H et al (2009) Guidelines on the management of co-occurring alcohol and other drug and mental health conditions in alcohol and other drug treatment settings. National Drug and Alcohol Research Center, Sydney
Pope K (1992) Responsibilities in providing psychological test feedback to clients. Psychol Assess 4:268–271
Raes V (2012) Assess and give feedback! The effect of using assessment instruments on substance-abuse outpatients’ adherence to treatment. Dissertation, Ghent University
Raes V, De Jong CAJ, De Bacquer D et al (2011) The effect of using assessment instruments on substance-abuse outpatient adherence to treatment: a multicenter randomized controlled trial. BMC Health Serv Res 11:123–132
Rapaport MH, Tipp JE, Schuckit MA (1993) A comparison of ICD-10 and DSM-III-R criteria for substance abuse and dependence. Am J Drug Alcohol Abuse 19:143–151
Schippers GM, Broekman TG, Buchholz A et al (2010) Measurement in the addictions for triage and evaluation (MATE): an instrument based on the World Health Organisation family of international classifications. Addiction 105:862–871
Sheehan DV, Lecrubier Y, Sheehan KH et al (1998) The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59:22–33
Smolka M, Stieglitz RD (1999) On the validity of the Bech-Rafaelsen Melancholia Scale (BRMS). J Affect Disord 54:119–128
Spitzer RL, Williams JBW (1980) Classification in psychiatry. In: Kaplan HI, Freeman AM, Sadock BJ (eds) Comprehensive textbook of Psychiatry, 4th edn. Williams & Williams, Baltimore, pp 591–613
Tiet QQ, Finney JW, Moos RH (2008) Screening psychiatric patients for illicit drug use disorders and problems. Clin Psychol Rev 28:578–591
UCLA Integrated Substance Abuse Programs (2006) Drug dependence treatment: training package Volume A: Screening, assessment, and treatment planning. UNODC-Office on Drugs and Crime. http://www.unodc.org/ddt-training/treatment/a.html
Üstün TB, Wittchen HU (1992) Instruments for the assessment of substance use disorders. Curr Opin Psychiatry 5:412–419
Wing JK, Sartorius N, Üstün TB (1992) Diagnosis and clinical measurement in psychiatry: a reference manual for SCAN. University Press, London
Wittchen HU, Robins LN, Gottler LB et al (1991) Cross-cultural feasibility, reliability and sources of variance of the Composite International Diagnostic Interview (CIDI). The Multicentre WHO/ADAMHA Field Trials. Br J Psychiatry 159:645–653
World Health Organization (1995) Schedules for clinical assessment in neuropsychiatry (SCAN). WHO, Geneva
World Health Organization (1997) Composite International Diagnostic Interview (CIDI) Version 2.1. WHO, Geneva
World Health Organization (2013) Alcohol, smoking and substance involvement screening test (ASSIST). http://www.who.int/substance_abuse/activities/assist_test/en. Accessed 14 Aug 2013
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Stieglitz, RD., Raes, V. (2015). Assessment Strategies and Instruments in DD. In: Dom, G., Moggi, F. (eds) Co-occurring Addictive and Psychiatric Disorders. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-45375-5_17
Download citation
DOI: https://doi.org/10.1007/978-3-642-45375-5_17
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-45374-8
Online ISBN: 978-3-642-45375-5
eBook Packages: MedicineMedicine (R0)